Elite Pharmaceuticals, Inc. reported consolidated revenues of $18.9 million for Q2 FY2025, a 33% increase year-over-year, driven by strong sales in its Elite label product line. Operating profits surged 84% to $3.5 million compared to the same quarter last year. The company will host a conference call on November 15, 2024, to discuss these results and recent developments.
Elite Pharmaceuticals, Inc. has announced its financial results for the first quarter of fiscal year 2025, which ended on June 30, 2024. The company also provided details regarding an upcoming conference call to discuss these results further.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
